Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
Sastre J, Maestro ML, Gómez-España A, Rivera F, Valladares M, Massuti B, Benavides M, Gallén M, Marcuello E, Abad A, Arrivi A, Fernández-Martos C, González E, Tabernero JM, Vidaurreta M, Aranda E, Díaz-Rubio E. Sastre J, et al. Among authors: maestro ml. Oncologist. 2012;17(7):947-55. doi: 10.1634/theoncologist.2012-0048. Epub 2012 May 29. Oncologist. 2012. PMID: 22643538 Free PMC article. Clinical Trial.
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Sotelo MJ, Sastre J, Maestro ML, Veganzones S, Viéitez JM, Alonso V, Grávalos C, Escudero P, Vera R, Aranda E, García-Alfonso P, Gallego-Plazas J, Lopez C, Pericay C, Arrivi A, Vicente P, Ballesteros P, Elez E, López-Ladrón A, Díaz-Rubio E. Sotelo MJ, et al. Among authors: maestro ml. Ann Oncol. 2015 Mar;26(3):535-41. doi: 10.1093/annonc/mdu568. Epub 2014 Dec 15. Ann Oncol. 2015. PMID: 25515656 Free article.
Telomerase activity as a prognostic factor in colorectal cancer.
Sanz-Casla MT, Vidaurreta M, Sanchez-Rueda D, Maestro ML, Arroyo M, Cerdán FJ. Sanz-Casla MT, et al. Among authors: maestro ml. Onkologie. 2005 Nov;28(11):553-7. doi: 10.1159/000088525. Onkologie. 2005. PMID: 16249640 Clinical Trial.
Circulating tumour cells in locally advanced breast cancer.
García-Sáenz JA, Martín M, Maestro ML, Vidaurreta M, Veganzones S, Rafael S, Casado A, Bobokova J, Sastre J, De la Orden V, Arroyo M, Díaz-Rubio E. García-Sáenz JA, et al. Among authors: maestro ml. Clin Transl Oncol. 2009 Aug;11(8):544-7. doi: 10.1007/s12094-009-0400-4. Clin Transl Oncol. 2009. PMID: 19661030
Prognostic significance of the p185 protein in colorectal cancer.
Sanz-Casla MT, Vidaurreta M, Maestro ML, López JA, Jiménez F, Fernández C, Maestro C, Balibrea JL, Cerdán FJ. Sanz-Casla MT, et al. Among authors: maestro ml, maestro c. Rev Esp Enferm Dig. 2004 Feb;96(2):102-9. doi: 10.4321/s1130-01082004000200003. Rev Esp Enferm Dig. 2004. PMID: 15255019 Free article. English, Spanish.
50 results